Tenofovir vs. Entecavir after treatment for HBV-associated HCC

Published Date: 08 Mar 2023

This review compared the effectiveness of entecavir and tenofovir in reducing relapses and mortality after treatment for HBV-related hepatocellular carcinoma.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Adjuvant ICIs: A Winner and a Loser in Clear Cell Renal Cell Carcinoma?

2.

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

3.

In cancer survivors, loneliness is associated with a higher risk of death.

4.

Researchers discover cellular 'doorway' exploited by cancer-causing virus

5.

Pomalidomide Reduces Severe Epistaxis in Hereditary Bleeding Disease.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot